Is Ki-67 of Diagnostic Value in Distinguishing Between Partial and Complete Hydatidiform Moles? A Systematic Review and Meta-analysis

Anticancer Res. 2018 Feb;38(2):1105-1110. doi: 10.21873/anticanres.12329.

Abstract

Background/aim: To demonstrate the value of Ki-67 in distinguishing between partial and complete hydatidiform moles.

Materials and methods: We searched electronic databases included Medline, WOK, Cochrane Library and CNKI, through January 24, 2015. Experts were consulted, and references from related articles were examined. The meta-analysis was conducted with RevMan5.3, according to the PRISMA guidelines. Mantel-Haenszel estimates were calculated and pooled under a random effect model, with data expressed as odds ratio (OR) and 95% confidence interval (CI).

Results: We analyzed eight trials with a total of 337 participants who underwent uterine curettage and met the inclusion criteria. A significantly higher expression of Ki-67 was observed in complete than in partial hydatidiform moles (OR=3.28; 95%CI=1.80-5.96; p<0.0001).

Conclusion: The Ki-67 expression was higher in complete than in partial hydatidiform moles. Therefore, Ki-67 may be of diagnostic value in distinguishing between partial and complete hydatidiform moles. However, the present study had only a limited number of samples, so investigation of a greater number of cases is needed to confirm this conclusion.

Keywords: Diagnosis; Ki-67 antigen; hydatidiform mole; meta-analysis.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Female
  • Humans
  • Hydatidiform Mole / classification*
  • Hydatidiform Mole / diagnosis*
  • Hydatidiform Mole / metabolism
  • Ki-67 Antigen / metabolism*
  • Pregnancy
  • Prognosis
  • Uterine Neoplasms / classification
  • Uterine Neoplasms / diagnosis*
  • Uterine Neoplasms / metabolism

Substances

  • Biomarkers, Tumor
  • Ki-67 Antigen